Tofacitinib, Biologic DMARDs Associated with Higher Risk of Herpes Zoster in Patients with Rheumatoid Arthritis
Pharmacy Times,
Treatment with biologic disease-modifying antirheumatic drugs associated with a higher overall risk, incidence, and recurrence…